Submit Full Adverse Event Data from Lenvatinib Phase IV Liver Cancer Trial: CDSCO Panel To Eisai Pharma Parthika Patel4 July 2025 1:00 PM ISTNew Delhi: In a recent regulatory review, the Subject Expert Committee (SEC) under the Oncology division of the Central Drugs Standard Control...
Intas Gets SEC Nod to Import, Market Anti-Cancer Drug Serplulimab, Phase IV Trial Mandated Dr. Divya Colin29 Jun 2025 1:00 PM ISTNew Delhi: Intas Pharmaceutical has received approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Gilead Sciences, Kymera Therapeutics ink pact to develop novel oral molecular glue CDK2 degraders Ruchika Sharma26 Jun 2025 10:15 AM ISTFoster City: Gilead Sciences, Inc. and Kymera Therapeutics, Inc., have entered into an exclusive option and license agreement for accelerating...
Biocon Gets CDSCO Panel Nod to Market Trastuzumab PGS in India Dr. Divya Colin25 Jun 2025 4:51 PM ISTNew Delhi: The Subject Expert Committee (SEC) on Oncology and Hematology, functioning under the Central Drugs Standard Control Organisation (CDSCO),...
Intas Gets CDSCO Panel Nod to Conduct Phase III Trial of Pertuzumab Biosimilar for Breast Cancer Dr. Divya Colin11 Jun 2025 5:45 PM ISTNew Delhi: Intas Pharmaceuticals has received approval from the Subject Expert Committee (SEC), functioning under the Central Drugs Standard...
Study assesses Impact of Lingual Nerve Block on Hemodynamic Stability During Tongue Cancer Surgery: Study Dr Monish Raut9 May 2025 8:30 PM ISTRecently published randomized controlled trial involved 132 patients undergoing wide local excision of unilateral tongue cancer to evaluate the...
Uro-Oncology Fellowship Programme duration 2 years, not 1: AIIMS issues corrigendum Divyani Paul16 April 2025 1:26 PM ISTNew Delhi- The All India Institute of Medical Sciences (AIIMS), New Delhi, has issued a corrigendum regarding the course duration of the Fellowship...
KKR to Buy 51% Stake in Cancer Chain HCG for Rs 3,128 Crore Farhat Nasim16 Feb 2025 10:15 AM ISTBengaluru: Bengaluru-based cancer care network Healthcare Global Enterprises Ltd (HCG) is set for a major ownership transfer, as private equity giant...
Shilpa Medicare Gets CDSCO Panel Nod for Novel NAFLD Drug, Advances to Marketing Approval Stage Farhat Nasim14 Feb 2025 2:04 PM ISTRaichur: Shilpa Medicare Limited, recently announced that its Investigational New Drug (IND), Nor-Ursodeoxycholic Acid Tablets (500 mg), has received...
CDSCO Releases Draft: 1,178 Medical Devices to be Reclassified into 4 Categories, AiMeD Welcomes Move Farhat Nasim11 Jan 2025 6:09 PM ISTHowever, AiMeD urged regular meetings with stakeholders to clarify compliance and align Medical Device Rules interpretations across regulators.
Interrelation between Heart Failure and Cancer may need Multidisciplinary Approach, suggests study Dr.Niharika Harsha B29 Oct 2024 8:45 AM ISTA recent scientific statement from the Heart Failure Society of America discussed the various risk factors, mechanisms, diagnosis, and management...
Why Hospitals Need to Focus More on Personalize and Customize Precision Treatment in Oncology? - Dr Manoj Lokhande Dr Manoj Lokhande16 July 2024 3:23 PM IST Offering tailor-made treatment for patients will bring a revolutionary change and successful prognosis of cancer. This article highlights the...
